Recurrent Adult Lymphoblastic Lymphoma

1

Review clinical trials related to Recurrent Adult Lymphoblastic Lymphoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

This phase II trial studies the side effects and how well combination chemotherapy works in treating patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, Burkitt lymphoma/leukemia, or double-hit lymphoma/leukemia that has come back or does not respond to treatment. Drugs used in chemotherapy, such as clofarabine, etoposide, cyclophosphamide, vincristine sulfate liposome, dexamethasone and bortezomib, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

Participants needed: 42
Trial details
Phase: Phase 2Age: 15+Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: Feb 17, 2026Locations: 1
Eligibility criteria

Relapsed and/or refractory Philadelphia negative acute lymphoblastic leukemia or... [+8]

Active >= grade 3 peripheral neuropathy [+4]